BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 15564408)

  • 1. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
    Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
    Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.
    Gazelle GS; Hunink MG; Kuntz KM; McMahon PM; Halpern EF; Beinfeld M; Lester JS; Tanabe KK; Weinstein MC
    Ann Surg; 2003 Apr; 237(4):544-55. PubMed ID: 12677152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases.
    Kim H; Gill B; Beriwal S; Huq MS; Roberts MS; Smith KJ
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1175-83. PubMed ID: 27130789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases.
    Abbott DE; Sohn VY; Hanseman D; Curley SA
    J Surg Oncol; 2014 May; 109(6):516-20. PubMed ID: 24374772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
    J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis.
    Karuna ST; Thirlby R; Biehl T; Veenstra D
    J Surg Oncol; 2008 Apr; 97(5):396-403. PubMed ID: 18270972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
    de Baere T; Elias D; Dromain C; Din MG; Kuoch V; Ducreux M; Boige V; Lassau N; Marteau V; Lasser P; Roche A
    AJR Am J Roentgenol; 2000 Dec; 175(6):1619-25. PubMed ID: 11090390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
    Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J
    Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of liver metastases from colorectal cancer].
    Popescu I; Ionescu M; Alexandrescu S; Ciurea S; Hrehoreţ D; Sârbu-Boeţi P; Boroş M; Croitoru A; Anghel R
    Chirurgia (Bucur); 2006; 101(1):13-24. PubMed ID: 16623372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of colorectal cancer with synchronous bilobar liver metastases with simultaneous bowel and liver resection plus radiofrequency ablation.
    Julianov A; Karashmalakov A; Rachkov I; Hristov H
    Hepatogastroenterology; 2004; 51(57):643-5. PubMed ID: 15143882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms.
    Shetty SK; Rosen MP; Raptopoulos V; Goldberg SN
    J Vasc Interv Radiol; 2001 Jul; 12(7):823-33. PubMed ID: 11435538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.